<?xml version="1.0" encoding="UTF-8"?>
<p>Annexin A1 serves as one of the many ligands for formyl peptide receptor 2 (FPR2) (
 <xref rid="B47" ref-type="bibr">Maderna et al., 2010</xref>; 
 <xref rid="B7" ref-type="bibr">Bena et al., 2012</xref>). FPR2, also called Lipoxin A4 receptor, is a G-protein coupled receptor with plasticity in its interacting ligands mediating both a pro-inflammatory and pro-resolution effector response (
 <xref rid="B84" ref-type="bibr">Walther et al., 2000</xref>; 
 <xref rid="B24" ref-type="bibr">Dufton et al., 2010</xref>; 
 <xref rid="B19" ref-type="bibr">Cooray et al., 2013</xref>). FPR2 is expressed in intestinal epithelial cells, neutrophils, macrophages, and microglial cells (
 <xref rid="B11" ref-type="bibr">Bonnans et al., 2006</xref>; 
 <xref rid="B15" ref-type="bibr">Chiang et al., 2006</xref>; 
 <xref rid="B5" ref-type="bibr">Barnig et al., 2013</xref>). As a receptor for ANXA1, understanding its role during IAV infection is essential to develop therapeutics targeting the viral disease.
</p>
